Related Experiment Video
Updated: Jul 10, 2026

Chemical Cartography Approaches to Study Trypanosomatid Infection
Published on: January 21, 2022
Matrix Effects and Analytical Instability in Pharmaceutical Bioanalysis: Current Challenges and Future Directions
Hemn A H Barzani1, Rebaz Anwar Omer2, Nergz Bayiz Abdulrahman3
1Department of Medical Laboratory Science, College of Health Science, Lebanese French University, Erbil, Iraq.
Abstract:
Pharmaceutical bioanalysis plays a central role in drug development, therapeutic drug monitoring, pharmacokinetics, metabolomics, and clinical diagnostics; however, the increasing complexity of biological and pharmaceutical matrices has created major analytical challenges related to matrix effects and analyte instability. Endogenous compounds such as phospholipids, proteins, salts, metabolites, and formulation excipients can interfere with chromatographic separation and electrospray ionization, leading to ion suppression or enhancement, signal fluctuations, reduced sensitivity, and compromised quantitative accuracy. In addition, hydrolysis, oxidation, photodegradation, enzymatic degradation, and adsorption processes can significantly affect analyte stability during sample collection, storage, preparation, and LC-MS analysis. This review critically evaluates the mechanistic basis of matrix effects and analytical instability in pharmaceutical bioanalysis and highlights recent advances in intelligent analytical technologies designed to improve analytical robustness, reproducibility, and sustainability. Advanced sample preparation strategies, including selective SPE, phospholipid-removal systems, MIP, and microextraction technologies, together with modern LC-MS platforms such as UHPLC-MS/MS and HRMS, have significantly enhanced trace-level pharmaceutical analysis in complex matrices. Furthermore, artificial intelligence-assisted workflows, microfluidics, biosensors, and omics-based analytical systems are transforming pharmaceutical bioanalysis toward automated and smart analytical ecosystems. Future pharmaceutical bioanalysis is expected to integrate intelligent, sustainable, and highly automated analytical systems that combine AI-driven analytics, advanced LC-MS technologies, green and white analytical chemistry principles, and harmonized regulatory frameworks to improve clinical applicability, analytical reliability, and environmental sustainability.
Related Concept Videos
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Measurement of Bioavailability: Pharmacodynamic Methods
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
